![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Taizhou City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Rivastigmine, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2013-080 - Rev 00
This Chemical Type CEP, issued on February 18, 2015, remains in force until February 18, 2020, ensuring its reliability within the pharmaceutical industry.
Substance Number 2629 associated with this CEP further emphasizes